TY - JOUR
T1 - Uterus transplantation
T2 - An update and the Middle East perspective
AU - Akouri, Randa
AU - Maalouf, Ghassan
AU - Abboud, Joseph
AU - Waked, Abbo
AU - Nakad, Toufic
AU - Bedran, Farid
AU - Gjannam, Gael Abou
AU - Hajj, Pascal
AU - Hanafy, Ash
AU - Brännström, Filip
AU - Merzah, Shafaq
AU - Gharhemani, Manda
AU - Dahm-Kähler, Pernilla
AU - Brännström, Mats
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Uterus transplantation (UTx) is the only available treatment for absolute uterine factor infertility (AUFI), which is caused by either absence (congenital or after hysterectomy) or presence of a non-functioning uterus. Uterus transplantation became a clinical reality after more than 10. years of structured animal-based research. Aside from gestational surrogacy, this procedure is the only alternative for women with AUFI to attain genetic motherhood. In the Middle East, North Africa and Turkey (MENAT) region, out of a population of around 470. million, more than 100,000 women of fertile age are estimated to suffer from AUFI. Introduction of UTx as an infertility treatment in this region will certainly differ in specific countries from ethical, religious and legal standpoints depending on culture and religion. The MENAT region is the cradle of three religions and the geographic area encompasses a variety of cultures and religions with different views on assisted reproduction. In light of these issues, the aim of this article is to give an overview of the research-based development of UTx and its clinical results up until today as well as to explore how UTx would fit into current infertility treatments in the MENAT region, with its existing multifaceted religious perspectives.
AB - Uterus transplantation (UTx) is the only available treatment for absolute uterine factor infertility (AUFI), which is caused by either absence (congenital or after hysterectomy) or presence of a non-functioning uterus. Uterus transplantation became a clinical reality after more than 10. years of structured animal-based research. Aside from gestational surrogacy, this procedure is the only alternative for women with AUFI to attain genetic motherhood. In the Middle East, North Africa and Turkey (MENAT) region, out of a population of around 470. million, more than 100,000 women of fertile age are estimated to suffer from AUFI. Introduction of UTx as an infertility treatment in this region will certainly differ in specific countries from ethical, religious and legal standpoints depending on culture and religion. The MENAT region is the cradle of three religions and the geographic area encompasses a variety of cultures and religions with different views on assisted reproduction. In light of these issues, the aim of this article is to give an overview of the research-based development of UTx and its clinical results up until today as well as to explore how UTx would fit into current infertility treatments in the MENAT region, with its existing multifaceted religious perspectives.
UR - http://www.scopus.com/inward/record.url?scp=85018783239&partnerID=8YFLogxK
U2 - 10.1016/j.mefs.2017.04.003
DO - 10.1016/j.mefs.2017.04.003
M3 - Article
AN - SCOPUS:85018783239
SN - 1110-5690
VL - 22
SP - 163
EP - 169
JO - Middle East Fertility Society Journal
JF - Middle East Fertility Society Journal
IS - 3
ER -